indium In 111 bevacizumab
Term · Oncology and biomedicine · MLC-T-ONC-014411
A radioimmunoconjugate comprised of the recombinant humanized monoclonal antibody bevacizumab conjugated with the gamma-emitting radioisotope indium In 111. Indium I 111 bevacizumab binds to vascular endothelial growth factor (VEGF), allowing the detection of VEGF distribution using gamma scintigraphy.
| Identifier | MLC-T-ONC-014411 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | 111-indium labeled bevacizumab |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-014411",
"term": "indium In 111 bevacizumab",
"field": "Oncology and biomedicine",
"definition": "A radioimmunoconjugate comprised of the recombinant humanized monoclonal antibody bevacizumab conjugated with the gamma-emitting radioisotope indium In 111. Indium I 111 bevacizumab binds to vascular endothelial growth factor (VEGF), allowing the detection of VEGF distribution using gamma scintigraphy.",
"synonyms": [
"111-indium labeled bevacizumab"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/indium-in-111-bevacizumab/"
}
Record 9,181 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.